SCHEDULE 13G: Bank of America Discloses 5.4% Passive Stake in RxSight, Inc.

Bank of America Corporation and its subsidiaries have reported a passive beneficial ownership of 5.4% in RxSight, Inc., totaling 2,181,788 shares of common stock as of December 31, 2024.

Summary

• Bank of America Corp /DE/ and its wholly-owned subsidiaries, including Bank of America N.A., BofA Securities, Inc., Merrill Lynch International, and Merrill Lynch Pierce Fenner & Smith, Inc., are the reporting persons.
• The reporting persons beneficially own an aggregate of 2,181,788 shares of RxSight, Inc. common stock.
• This ownership represents 5.4% of the total outstanding common stock of RxSight, Inc.
• The shares are held with shared voting power over 2,059,348 shares and shared dispositive power over 2,181,399 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of RxSight, Inc.

Sentiment

Score: 5

Explanation: This is a routine disclosure of a passive ownership stake by a financial institution, providing no direct positive or negative operational or financial news about the issuer, RxSight, Inc.

Positives

• A major financial institution, Bank of America, has disclosed a significant passive stake in RxSight, Inc., indicating its inclusion in their ordinary course of business investment portfolios.

Negatives

• No specific negative information regarding RxSight, Inc.'s performance or outlook is disclosed in this filing.

Risks

• The filing itself does not detail specific risks related to RxSight, Inc.'s operations or financial health.

Future Outlook

This Schedule 13G filing does not provide any forward-looking statements or guidance regarding RxSight, Inc.'s future outlook.

Management Comments

• Andres Ortiz, Authorized Signatory for Bank of America Corp /DE/, certified that the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing the control of RxSight, Inc.

Industry Context

This filing primarily concerns a change in institutional ownership structure rather than providing insights into broader industry trends or competitive landscape for RxSight, Inc.

Stakeholder Impact

• Shareholders: The disclosure of a significant passive stake by a major financial institution like Bank of America may be perceived by some shareholders as a positive signal of institutional confidence in RxSight, Inc.
• Employees, Customers, Suppliers, Creditors: This filing, being a passive ownership disclosure, does not indicate any direct operational or strategic changes that would immediately impact employees, customers, suppliers, or creditors of RxSight, Inc.

Key Dates

Keywords

RxSight Inc., Bank of America, Schedule 13G, beneficial ownership, common stock, passive investment, institutional ownership